In the News

Press Releases and Media Coverage

December 2, 2024

The Bio Report Podcast: Getting Tumors to Say “Eat Me”

Read Article
November 8, 2024

The Cancer Letter: Preclinical Data Show Anti-CD24 Macrophage Checkpoint Inhibitor Promotes Phagocytosis and Shrinks Tumors

Read Article
November 7, 2024

Pheast Presents New Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor, at SITC 2024

Read Article
November 6, 2024

GEN: Parallel Platform Approach Slashes Process Development Time

Read Article
September 3, 2024

Drug Discovery Online: Does Targeting Macrophages Hold The Key For Treating Cancer?

Read Article
July 31, 2024

Cancer Research: Attacking Cancer Through Activating “Big Eaters” of the Immune System

Read Article
June 26, 2024

PharmaShots: Macrophage Checkpoint Therapy with Roy Maute from Pheast Therapeutics

Read Article
May 13, 2024

Pheast Unveils First Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor

Read Article
January 5, 2024

Drug Target Review: The Potential of CD24 in Cancer Immunotherapy

Read Article
November 15, 2023

Pheast Featured as One of Nature Biotechnology’s Top Academic Spinouts for 2023

Read Article